Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More
Xconomy
AUGUST 19, 2016
This time for me, it’s volleyball. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Patent Office in its successful push to get pioneering patents for the CRISPR-Cas9 gene-editing technology.
40 
Let's personalize your content